BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16598444)

  • 1. Prolonged asystole provoked by head-up tilt testing.
    Winker R; Frühwirth M; Saul P; Rüdiger HW; Pezawas T; Schmidinger H; Moser M
    Clin Res Cardiol; 2006 Jan; 95(1):42-7. PubMed ID: 16598444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of prolonged asystole during head-up tilt testing.
    Sucu M; Sari I; Davutoğlu V
    Turk Kardiyol Dern Ars; 2009 Jul; 37(5):345-7. PubMed ID: 19875910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A patient treated with tilt training and midodrine after 68 seconds asystole during head-up tilt table testing.
    Oz F; Cizgici Y; Bilge AK
    Acta Cardiol; 2011 Aug; 66(4):523-5. PubMed ID: 21894812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproducibility of tilt-table test result in patients with malignant neurocardiogenic syncope.
    Omar AR; Ng KS; Ng WL; Sutandar A
    Intern Med J; 2004 Aug; 34(8):504-6. PubMed ID: 15317550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant neurocardiogenic vasovagal syncope associated with chronic exaggerated vagal tone.
    Nakagawa M; Takahashi N; Yufu K; Fujino T; Ooie T; Yonemochi H; Nobe S; Hara M; Saikawa T; Ito M
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 1):1695-7. PubMed ID: 11138309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of patients with asystole induced by head-up tilt test.
    Barón-Esquivias G; Pedrote A; Cayuela A; Valle JI; Fernández JM; Arana E; Fernández M; Morales F; Burgos J; Martínez-Rubio A
    Eur Heart J; 2002 Mar; 23(6):483-9. PubMed ID: 11863351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducibility of head-up tilt-table testing in pediatric patients with neurocardiogenic syncope.
    Cohen GA; Lewis DA; Berger S
    Pediatr Cardiol; 2005; 26(6):772-4. PubMed ID: 16132274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility of asystole during head-up tilt testing in patients with neurally mediated syncope.
    Foglia-Manzillo G; Romanò M; Corrado G; Tagliagambe LM; Tadeo G; Spata M; Spinelli A; Grieco A; Santarone M
    Europace; 2002 Oct; 4(4):365-7. PubMed ID: 12408255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head-upright tilt table testing. A safe and easy way to assess neurocardiogenic syncope.
    Grubb BP; Kimmel S
    Postgrad Med; 1998 Jan; 103(1):133-8, 140. PubMed ID: 9448679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the effects of diverse therapeutic treatments versus no treatment of patients with neurocardiogenic syncope].
    Di Girolamo E; Di Iorio C; Sabatini P; Leonzio L; Barsotti A
    Cardiologia; 1998 Aug; 43(8):833-7. PubMed ID: 9808874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determinants of malignant vasovagal syncopes with asystole disclosed by the tilting test and therapeutic implications].
    Kouakam C; Lacroix D; Klug D; Ben Ameur Y; Guédon-Moreau L; Kacet S; Lekieffre J
    Ann Cardiol Angeiol (Paris); 1997 Mar; 46(3):135-43. PubMed ID: 9183393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged asystole during head-up tilt testing with clomipramine infusion.
    Leftheriotis DI; Theodorakis GN; Kremastinos DT
    Europace; 2003 Jul; 5(3):313-5. PubMed ID: 12842650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tilt-induced asystole: a useful prognostic marker or clinically unrelevant finding?
    Raviele A
    Eur Heart J; 2002 Mar; 23(6):433-7. PubMed ID: 11863344
    [No Abstract]   [Full Text] [Related]  

  • 14. Tilt testing in neurocardiogenic syncope: isosorbide versus isoproterenol.
    Hermosillo AG; Marquez MF; Jauregui-Renaud K; Falcon JC; Casanova JM; Guevara M; Cardenas M
    Acta Cardiol; 2000 Dec; 55(6):351-5. PubMed ID: 11227835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of asystole during tilt test-induced vasovagal syncope may depend on test methodology.
    Russo V; Parente E; Groppelli A; Rivasi G; Tomaino M; Gargaro A; Giacopelli D; Ungar A; Parati G; Fedorowski A; Sutton R; van Dijk JG; Brignole M
    Europace; 2023 Feb; 25(2):263-269. PubMed ID: 36796797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time- and frequency-domain analysis of beat to beat P-wave duration, PR interval and RR interval can predict asystole as form of syncope during head-up tilt.
    Piccirillo G; Moscucci F; Fiorucci C; Di Iorio C; Mastropietri F; Magrì D
    Physiol Meas; 2016 Nov; 37(11):1910-1924. PubMed ID: 27681167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocardiogenic syncope: a case of prolonged asystole.
    Serra P; Paparella G; Cazzin R
    Ital Heart J; 2004 May; 5(5):396-8. PubMed ID: 15185906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocardiogenic syncope in a 10-year-old boy.
    Meyer K; Galler A; Lietz R; Siekmeyer W
    Pediatr Cardiol; 2001; 22(5):415-6. PubMed ID: 11526422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical findings as predictors of positivity of head-up tilt table test in neurocardiogenic syncope.
    Asensio E; Oseguera J; Loría A; Gómez M; Narváez R; Dorantes J; Hernández P; Orea A; Rebollar V; Ocaranza R
    Arch Med Res; 2003; 34(4):287-91. PubMed ID: 12957525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of orthostatic self-training on head-up tilt testing for the prevention of tilt-induced neurocardiogenic syncope: comparison of pharmacological therapy.
    Abe H; Sumiyoshi M; Kohshi K; Nakashima Y
    Clin Exp Hypertens; 2003 Apr; 25(3):191-8. PubMed ID: 12716081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.